Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Etanercept effectively treated a severe skin condition when other treatments failed.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Apremilast did not work for treating severe alopecia areata.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.